| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/10/2007 | US20070105750 Novel plasma protein affinity tags |
| 05/10/2007 | US20070105225 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 05/10/2007 | US20070105219 Retrovirus from the HIV group and its use |
| 05/10/2007 | US20070105218 Lupus antibodies for passive immunotherapy of hiv/aids |
| 05/10/2007 | US20070105203 Enterobacteriaceae fermentation strains |
| 05/10/2007 | US20070105198 Genetic engineering; libraries; lung cells; hybrids; process control; controlling activation; antiinflammatory agents; autoimmune diseases; infections; bone disorders; anticancer agents; drug screening |
| 05/10/2007 | US20070105197 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids |
| 05/10/2007 | US20070105196 Modified green fluorescent proteins and methods for using same |
| 05/10/2007 | US20070105195 Entropic bristle domain sequences and their use in recombinant protein production |
| 05/10/2007 | US20070105193 Severe acute respiratory syndrome DNA vaccine compositions and methods of use |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070105182 modified by substituting negatively charged amino acids with positively charged amino acids on the exterior of the protein making the protein cell permeable; obviates the need for transfections |
| 05/10/2007 | US20070105178 a purified neural precursor cell-expressed developmentally down regulated (NEDD)8-activating protein beta subunit (NAE1-beta), used for detecting and/or modulating the conjugation of NEDD8 and/or its transfer to a target proteins |
| 05/10/2007 | US20070105172 A gene construct incorporating any two luciferase genes which emit lights with different colors using an identical substrate such that the gene can be stably expressed in mammalian cells; optimize a reporter gene capable of determining or quantifying multiple transcription activities simultaneosly |
| 05/10/2007 | US20070105167 Virulence Associated Nucleic Acid Sequences and Uses Thereof |
| 05/10/2007 | US20070105164 Cancer diagnosis and therapy |
| 05/10/2007 | US20070105162 Monovalent avidin and streptavidin compositions |
| 05/10/2007 | US20070105161 Identifying gamma -secretase inhibitors that exhibit reduced induction of goblet cell metaplasia; detecting mucin-2 induction or mucin-5AC induction in Notch expressing HT29 cells contacted with a compound that inhibits gamma -secretase |
| 05/10/2007 | US20070105159 Identifying compound that modulates signal transduction by measuring its binding and comparing to sugar; G-protein coupled receptor polypeptide |
| 05/10/2007 | US20070105158 Recombined cell system for deorphanizing g protein-coupled receptors |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070105149 Assay for diabetes |
| 05/10/2007 | US20070105148 Sphingosine 1-phosphate receptor gene, SPPR |
| 05/10/2007 | US20070105145 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions. |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070105137 Determining whether a naturally occurring strain of algae is toxic, comprisingdetermining whether a sample obtained from said strain of algae comprises a nucleic acid encoding a specific polypeptide; harmful algal blooms; shellfish; gene expression |
| 05/10/2007 | US20070105135 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/10/2007 | US20070105131 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/10/2007 | US20070105129 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 05/10/2007 | US20070105122 Primers for synthesizing full-length cDNA and their use |
| 05/10/2007 | US20070105115 Promoter of the human fatp5 gene and uses |
| 05/10/2007 | US20070105098 Isolation and use of ryanodine receptors |
| 05/10/2007 | US20070104764 Recombinant production of antimicrobial peptides |
| 05/10/2007 | US20070104737 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 05/10/2007 | US20070104734 Recombinant viruses with heterologous envelope proteins |
| 05/10/2007 | US20070104732 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/10/2007 | US20070104731 Helicobacter proteins and vaccines |
| 05/10/2007 | US20070104726 Multimeric complexes of antigens and adjuvants |
| 05/10/2007 | US20070104724 Attaching substances to microorganisms |
| 05/10/2007 | US20070104723 Treatment of fibrotic disease |
| 05/10/2007 | US20070104720 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 05/10/2007 | US20070104718 Gene BRCC-1 and diagnostic and therapeutic uses thereof |
| 05/10/2007 | US20070104716 Methods for controlling pathological angiogenesis by inhibition of a6b4 integrin |
| 05/10/2007 | US20070104713 Nogo receptor homologs |
| 05/10/2007 | US20070104712 Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors |
| 05/10/2007 | US20070104708 Compositions, methods, and kits relating to resistin |
| 05/10/2007 | US20070104696 Use of cell lines to produce active therapeutic proteins |
| 05/10/2007 | US20070104686 Vaccines, immunotherapeutics and methods for using the same |
| 05/10/2007 | US20070104685 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 05/10/2007 | US20070104681 Inhibits Interleukin T Cell Inducible Factors (IL-TIF/IL-22)'s effect on cells |
| 05/10/2007 | US20070104680 Antibodies to natural killer stimulatory factor |
| 05/10/2007 | DE102005051789A1 Der Botulinus Neurotoxin A Proteinrezeptor und seine Anwendungen The botulinum neurotoxin A receptor protein and its applications |
| 05/10/2007 | CA2628843A1 Neurotrophin-derived peptide sequences |
| 05/10/2007 | CA2628408A1 Conditionally-immortalised pancreatic cells |
| 05/10/2007 | CA2628221A1 Compositions and methods for diagnosing and treating cancer |
| 05/10/2007 | CA2626079A1 A lentiviral vector-based vaccine |
| 05/10/2007 | CA2626061A1 Cell-free synthesis of membrane bound polypeptides |
| 05/10/2007 | CA2625505A1 Method for the production of .gamma.-linolenic acid and/or stearidonic acid in transgenic brassicaceae and linaceae |
| 05/10/2007 | CA2625106A1 Platelet aggregation inhibitor composition |
| 05/10/2007 | CA2617723A1 Novel cxc-chemokine antagonists |
| 05/10/2007 | CA2612479A1 Production of bone morphogenic proteins (bmps) in transgenic mammals |
| 05/09/2007 | EP1783229A2 GTP binding stress-related proteins and methods of use in plants |
| 05/09/2007 | EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 05/09/2007 | EP1783226A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783225A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783224A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/09/2007 | EP1783223A1 Fungal transcriptional activator PRTT from Aspergillus niger, useful in methods for producing polypeptides |
| 05/09/2007 | EP1783222A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity. |
| 05/09/2007 | EP1783221A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 05/09/2007 | EP1783219A1 Method of searching for novel drug discovery targets |
| 05/09/2007 | EP1783218A1 Hcv rna having novel sequence |
| 05/09/2007 | EP1783217A1 Stabilized proline transporter |
| 05/09/2007 | EP1783215A1 Angiostatin and method of use for inhibition of angiogenesis |
| 05/09/2007 | EP1783214A1 Mutant glycoprotein not modified with asparagine-linked sugar chain |
| 05/09/2007 | EP1783213A1 Novel glucose dehydrogenase |
| 05/09/2007 | EP1783210A1 Productivity augmenting protein factors, novel cell lines and uses thereof |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783140A2 Neovascular-specific peptides |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1783138A1 Method of purifying virus envelope |
| 05/09/2007 | EP1782823A2 IL-21 peptides and nucleic acids |
| 05/09/2007 | EP1782318A2 Methods and systems for predicting protein-ligand coupling specificities |
| 05/09/2007 | EP1782074A2 Biomarkers for osteoarthritis |
| 05/09/2007 | EP1782071A2 Covalent tethering of functional groups to proteins and substrates therefor |
| 05/09/2007 | EP1781821A2 Genetic loci associated with phytophthora tolerance in soybean |
| 05/09/2007 | EP1781791A2 Hemopexin fusion proteins |
| 05/09/2007 | EP1781781A2 Nucleic acid sequences encoding cel ii endonuclease |
| 05/09/2007 | EP1781777A1 Method for the genetic activation of cells and uses of said cells |
| 05/09/2007 | EP1781703A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 05/09/2007 | EP1781702A2 Nucleoproteins displaying native t cell receptor libraries |
| 05/09/2007 | EP1781701A2 Progesterone receptor structure |
| 05/09/2007 | EP1781700A1 Rage fusion proteins and methods of use |
| 05/09/2007 | EP1781699A1 Multimers of peptides |
| 05/09/2007 | EP1781698A2 Compositions and methods of using angiopoietin-like 4 protein |
| 05/09/2007 | EP1781697A2 Novel carbamylated epo and method for its production |
| 05/09/2007 | EP1781696A1 Novel phosphorylated phosphatase cdc25b sequences, antibodies directed against said sequences and uses thereof |
| 05/09/2007 | EP1781695A1 Selective vpac2 receptor peptide agonists |
| 05/09/2007 | EP1781694A1 Selective vpac2 receptor peptide agonists |
| 05/09/2007 | EP1781693A2 Selective vpac2 receptor peptide agonists |
| 05/09/2007 | EP1781692A2 Selective vpac2 receptor peptide agonists |